Inactive Instrument

Press Releases MEDH ACQU Nasdaq

Equities

MTACU

US58507N2045

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

MEDH ACQU : STANDBY EQUITY PURCHASE AGREEMENT - Form 8-K	23-10-03	PU
MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders	23-08-02	BU
MedTech Acquisition : Material Event - Form 8-K	23-08-02	PU
MEDTECH ACQUISITION CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	23-06-15	AQ
TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD Method with the TriNav Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting	23-06-13	AQ
TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting	23-06-12	BU
MEDTECH ACQUISITION CORP : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-06-08	AQ
TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD Method in Stage IV Uveal Melanoma Patients with Liver Metastases	23-04-21	AQ
MEDTECH ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-04-20	AQ
TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases	23-04-20	BU
MEDTECH ACQUISITION CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-04-05	AQ
MEDTECH ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-22	AQ
MEDTECH ACQUISITION CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-03-08	AQ
MEDTECH ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-02-21	AQ
TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business	23-02-21	BU
TriSalus Life Sciences Posts Updated Investor Presentation Highlighting Additional Phase 1 and 1b Clinical Data for Pressure-Enabled Regional Immuno-Oncology-01 and -02 Studies	23-02-17	AQ
MEDTECH ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-02-16	AQ
Text on screen: Dr. Carvajal is a Member of the TriSalus Scientific Advisory Board and Investigator for the PERIO-01 Study - Form 8-K	22-12-21	PU
MEDTECH ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-12-21	AQ
MedTech Acquisition : Material Agreement - Form 8-K	22-12-19	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases MEDH ACQU Nasdaq

Equities

MTACU

US58507N2045

Press Releases

Filters